LONDON, April 25, 2014 /PRNewswire/ --
Turkey, with its ambitious social and economic roadmap, is regarded as a rising star in the region. Its drive to promote pharmaceutical innovation, R&D and capital investment makes it the perfect meeting place for local Turkish and regional drug manufacturers to connect and strategize how best to take advantage of the huge opportunities which are available throughout the pharmaceutical supply chain.
CPhI, the leading organizer of business networking and professional development events for the pharmaceutical industry, has put together an important regional event where local Turkish and regional drug manufacturers, global suppliers of raw materials, machinery, packaging solutions and contract services can meet face-to-face to debate the challenges and opportunities of launching products in emerging markets, stay informed about the latest industry trends, hear important regulatory updates and remain one step ahead in a constantly changing pharmaceutical market.
One of the keynote speakers, Turgut Tokgöz, Secretary General, Pharmaceuticals Manufacturers Association of Turkey (IEIS) recently talked about the changing trends in Turkey's pharmaceutical industry and the challenges and opportunities: "Pharmaceuticals are one of the five industries the government has declared strategic to Turkey." However, despite being a strategic priority,
reimbursement prices for pharmaceuticals remain a hurdle to profitability and so export opportunities are also of growing importance. "Turkey supplies pharmaceutical products to 150 different countries."
The Official CPhi Istanbul Exhibition Conference will bring together key voices in the Turkish pharma industry to share strategies on how to achieve profitability in a lean margin Turkish market and to identify key opportunities for generics and biosimilars manufacturers operating in Turkey. It will also examine healthcare systems, market trends, regulatory requirements and competitive landscapes of Turkey's most significant export markets for pharmaceutical products. Attendees will benefit from enhancing their show visit with the opportunity to hear about the latest information in the pharmaceutical industry.
The event will host 23 conference sessions, split into six modules across two days and feature 30 Turkish & International Speakers from 14 countries, including including AbdiIbrahim, Roche, Nobel, Sanofi, Zentiva, Hikma Pharmaceuticals, Novartis, CinnaGen Co. The event will open with an impressive keynote theatre where high profile speakers from the Turkish Pharma industry who will outline healthcare trends, pharma innovation and investment, regulatory requirements, market strategies and opportunities. There will also be similar regional modules focusing on opportunities and challenges in the MENA and CIS regions. Day two will include modules on generics, biosimilars and partnerships and sourcing.
There are limited places left. Please go to http://www.cphi.com/istanbulconf for more information and special offers.
About CPhI Conferences:
CPhI Conferences deliver the latest pharma market insight, in-depth case studies and exceptional networking opportunities through a programme of high-level conferences. The worldwide series of events, spanning four continents, provides the optimum forum for you to learn, make new business connections and identify the latest growth opportunities. Delivered by expert teams in each region, every conference is extensively researched with leading professionals, ensuring that CPhI Conferences tackle the most business critical issues facing the pharma industry today. More info on http://www.cphiconferences.com/.
For further information, please contact:
Speaker & Content enquiries:
Senior Conference and Live Content Producer
Registration & Marketing enquiries:
SOURCE CPhI Conferences